Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPK-060 2% ear drops in acute external otitis
2011-004356-20Phase 2Completed
- Sponsor
- Pergamum AB
- Start
- Sep 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Acute External Otitis (AEO) comparing DPK-060 2% ear drops with Placebo ear drops (2 arms). Primary endpoint: Safety and tolerability of DPK-060 2% ear drops. Started Sep 2011; status: completed.
02
Drugs
DPK-060
03
Conditions
Acute External Otitis (AEO)
Beyond the preview
Go deeper on 2011-004356-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004356-20.